| Karen Adeline Purdy, MD | |
|
2715 Alkay Dr, Shreveport, LA 71118-2509 | |
| (318) 212-8951 | |
| (318) 212-6752 |
| Full Name | Karen Adeline Purdy |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2715 Alkay Dr, Shreveport, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932106952 | NPI | - | NPPES |
| 080157229 | Other | TN | RAILROAD MEDICARE |
| 140376 | Other | UNITED HEALTHCARE | |
| 3147088 | Other | TN | BCBS |
| 3851650 | Medicaid | TN | |
| 96964 | Other | AR | BCBS |
| 148975 | Medicaid | AL | |
| 00114317 | Medicaid | MS | |
| 2708986 | Other | CIGNA | |
| 1726672 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MD.018977 (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | MD.018977 (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
› Verified 7 days ago
| Entity Name | Wk Urgent Care Center-pierremont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639115132 PECOS PAC ID: 8123016946 Enrollment ID: O20040503000206 |
News Archive
Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
› Verified 7 days ago
| Entity Name | Jencare Neighborhood Medical Center Midcity, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194085852 PECOS PAC ID: 1557508579 Enrollment ID: O20130513000065 |
News Archive
Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Adeline Purdy, MD 2715 Alkay Dr, Shreveport, LA 71118-2509 Ph: (318) 212-8951 | Karen Adeline Purdy, MD 2715 Alkay Dr, Shreveport, LA 71118-2509 Ph: (318) 212-8951 |
News Archive
Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
› Verified 7 days ago
Ratnam Baby Nagalla, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 870 Olive St, Shreveport, LA 71104 Phone: 318-629-0480 Fax: 318-629-0483 | |
David Juston Colvin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8383 Millicent Way, Shreveport, LA 71115 Phone: 318-797-6661 Fax: 318-795-8512 | |
Susan Michelle Self, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8001 Youree Dr, Suite 540, Shreveport, LA 71115 Phone: 318-212-3810 Fax: 318-212-3815 | |
Dr. Kirk Anthony Grantham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2530 Bert Kouns Loop, Suite 138, Shreveport, LA 71118 Phone: 318-588-4726 Fax: 318-900-7828 | |
Ayesha Tabassom, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 Fax: 318-629-4833 | |
David Henry, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7813 Youree Dr, Shreveport, LA 71105 Phone: 318-212-3830 Fax: 318-212-3835 | |
Ammar Husan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 |